✦ LIBER ✦
Phase I and clinical pharmacology of a type I and II, 5-alpha-reductase inhibitor (LY320236) in prostate cancer: elevation of estradiol as possible mechanism of action
✍ Scribed by Mario A. Eisenberger; Menachem Laufer; Nicholas J. Vogelzang; Oliver Sartor; Donald Thornton; Blake Lee Neubauer; Victoria Sinibaldi; Gary Lieskovsky; Michael A. Carducci; Mariana Zahurak; Derek Raghavan
- Book ID
- 116943827
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 130 KB
- Volume
- 63
- Category
- Article
- ISSN
- 0090-4295
No coin nor oath required. For personal study only.